| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 94 | 2026 | 831 | 9.840 |
Why?
|
| Microbiota | 53 | 2023 | 438 | 6.060 |
Why?
|
| Bacteria | 48 | 2025 | 524 | 5.160 |
Why?
|
| RNA, Ribosomal, 16S | 62 | 2025 | 378 | 3.390 |
Why?
|
| Feces | 49 | 2026 | 720 | 3.040 |
Why?
|
| Metagenome | 25 | 2025 | 139 | 2.000 |
Why?
|
| Intestinal Mucosa | 19 | 2025 | 763 | 1.910 |
Why?
|
| Sequence Analysis, DNA | 32 | 2024 | 1694 | 1.890 |
Why?
|
| Gastrointestinal Tract | 16 | 2022 | 210 | 1.840 |
Why?
|
| Bronchiolitis | 15 | 2019 | 126 | 1.830 |
Why?
|
| Dysbiosis | 18 | 2026 | 143 | 1.660 |
Why?
|
| Metagenomics | 18 | 2026 | 114 | 1.650 |
Why?
|
| DNA, Bacterial | 28 | 2021 | 480 | 1.540 |
Why?
|
| Diabetes Mellitus, Type 1 | 14 | 2025 | 876 | 1.450 |
Why?
|
| Fungi | 6 | 2022 | 72 | 1.270 |
Why?
|
| Mycobiome | 3 | 2019 | 8 | 1.250 |
Why?
|
| Colon | 11 | 2025 | 363 | 1.240 |
Why?
|
| Intestines | 14 | 2024 | 587 | 1.240 |
Why?
|
| Tularemia | 2 | 2021 | 13 | 1.210 |
Why?
|
| Francisella tularensis | 3 | 2021 | 16 | 1.180 |
Why?
|
| Fecal Microbiota Transplantation | 12 | 2026 | 108 | 1.060 |
Why?
|
| Genome, Bacterial | 12 | 2017 | 199 | 1.060 |
Why?
|
| Weight Gain | 3 | 2019 | 383 | 1.000 |
Why?
|
| Bacterial Proteins | 9 | 2021 | 944 | 0.980 |
Why?
|
| Humans | 181 | 2026 | 130555 | 0.970 |
Why?
|
| Diet | 10 | 2025 | 1099 | 0.930 |
Why?
|
| Animals, Newborn | 7 | 2024 | 1018 | 0.900 |
Why?
|
| Nasopharynx | 9 | 2019 | 88 | 0.880 |
Why?
|
| Coculture Techniques | 2 | 2024 | 230 | 0.850 |
Why?
|
| Vagina | 4 | 2020 | 207 | 0.830 |
Why?
|
| Uterine Cervical Neoplasms | 6 | 2023 | 266 | 0.830 |
Why?
|
| Healthy Volunteers | 7 | 2020 | 154 | 0.820 |
Why?
|
| Escherichia coli | 14 | 2021 | 990 | 0.820 |
Why?
|
| Organoids | 2 | 2024 | 300 | 0.810 |
Why?
|
| Bacteriophages | 1 | 2025 | 102 | 0.790 |
Why?
|
| Probiotics | 8 | 2022 | 226 | 0.760 |
Why?
|
| Animals | 75 | 2025 | 33856 | 0.730 |
Why?
|
| Enterovirus | 4 | 2025 | 51 | 0.730 |
Why?
|
| Chromosomes, Bacterial | 3 | 2009 | 64 | 0.720 |
Why?
|
| Female | 103 | 2026 | 70425 | 0.680 |
Why?
|
| Metabolome | 9 | 2021 | 325 | 0.680 |
Why?
|
| Skin | 6 | 2019 | 539 | 0.670 |
Why?
|
| Male | 99 | 2026 | 64534 | 0.670 |
Why?
|
| Oxygen | 1 | 2024 | 550 | 0.660 |
Why?
|
| Mouth | 7 | 2020 | 69 | 0.660 |
Why?
|
| Chloride Channels | 1 | 2021 | 56 | 0.650 |
Why?
|
| Obesity | 8 | 2025 | 2384 | 0.620 |
Why?
|
| Mice | 46 | 2025 | 18215 | 0.620 |
Why?
|
| Genomics | 9 | 2026 | 1616 | 0.620 |
Why?
|
| Bacterial Load | 3 | 2020 | 34 | 0.580 |
Why?
|
| Pancreatitis, Chronic | 3 | 2026 | 85 | 0.570 |
Why?
|
| Protein-Energy Malnutrition | 2 | 2016 | 60 | 0.570 |
Why?
|
| Information Storage and Retrieval | 2 | 2018 | 65 | 0.570 |
Why?
|
| Environment | 3 | 2021 | 148 | 0.560 |
Why?
|
| DNA Viruses | 1 | 2018 | 30 | 0.560 |
Why?
|
| beta-Lactamases | 7 | 2002 | 213 | 0.560 |
Why?
|
| Respiratory Syncytial Virus, Human | 4 | 2025 | 241 | 0.550 |
Why?
|
| Respiratory Syncytial Virus Infections | 6 | 2025 | 395 | 0.550 |
Why?
|
| Immunity, Innate | 1 | 2021 | 410 | 0.550 |
Why?
|
| Mice, Inbred C57BL | 26 | 2024 | 4713 | 0.550 |
Why?
|
| Francisella | 1 | 2017 | 4 | 0.540 |
Why?
|
| Anti-Bacterial Agents | 14 | 2020 | 2578 | 0.540 |
Why?
|
| Longitudinal Studies | 11 | 2025 | 1486 | 0.540 |
Why?
|
| Biodiversity | 11 | 2021 | 72 | 0.530 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2019 | 323 | 0.530 |
Why?
|
| Electrophoresis | 1 | 2017 | 32 | 0.520 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2017 | 14 | 0.520 |
Why?
|
| Adult | 44 | 2026 | 31157 | 0.500 |
Why?
|
| beta-Lactam Resistance | 3 | 2009 | 48 | 0.500 |
Why?
|
| Inflammation | 8 | 2024 | 1485 | 0.500 |
Why?
|
| Weaning | 2 | 2016 | 52 | 0.480 |
Why?
|
| Specimen Handling | 5 | 2020 | 147 | 0.470 |
Why?
|
| Proteomics | 7 | 2024 | 616 | 0.470 |
Why?
|
| Butyrates | 4 | 2024 | 39 | 0.470 |
Why?
|
| Infant, Premature | 6 | 2020 | 856 | 0.470 |
Why?
|
| Growth | 1 | 2016 | 93 | 0.470 |
Why?
|
| Biota | 2 | 2012 | 5 | 0.470 |
Why?
|
| Lymph Nodes | 1 | 2017 | 356 | 0.460 |
Why?
|
| Enterovirus Infections | 3 | 2025 | 48 | 0.460 |
Why?
|
| Insulin | 8 | 2025 | 1140 | 0.460 |
Why?
|
| Escherichia coli Infections | 5 | 2021 | 194 | 0.460 |
Why?
|
| Prebiotics | 3 | 2023 | 29 | 0.450 |
Why?
|
| Islets of Langerhans | 4 | 2023 | 160 | 0.450 |
Why?
|
| Disease Models, Animal | 19 | 2025 | 4672 | 0.450 |
Why?
|
| Fatty Acids, Volatile | 5 | 2025 | 43 | 0.450 |
Why?
|
| Infant | 31 | 2025 | 13270 | 0.440 |
Why?
|
| Genome, Viral | 4 | 2026 | 167 | 0.440 |
Why?
|
| Metabolic Networks and Pathways | 7 | 2022 | 192 | 0.440 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2023 | 1444 | 0.440 |
Why?
|
| Pancreas | 3 | 2025 | 219 | 0.440 |
Why?
|
| Genotype | 4 | 2025 | 2592 | 0.430 |
Why?
|
| Autoimmunity | 8 | 2025 | 176 | 0.430 |
Why?
|
| Prospective Studies | 21 | 2026 | 6438 | 0.430 |
Why?
|
| Whole Genome Sequencing | 4 | 2021 | 358 | 0.430 |
Why?
|
| Genome | 2 | 2022 | 453 | 0.430 |
Why?
|
| Precision Medicine | 1 | 2018 | 385 | 0.420 |
Why?
|
| Machine Learning | 4 | 2026 | 381 | 0.420 |
Why?
|
| Phylogeny | 14 | 2025 | 687 | 0.420 |
Why?
|
| Oligosaccharides | 3 | 2020 | 72 | 0.410 |
Why?
|
| Software | 2 | 2018 | 732 | 0.410 |
Why?
|
| Insulin Resistance | 3 | 2025 | 687 | 0.400 |
Why?
|
| Bacteremia | 2 | 2017 | 430 | 0.400 |
Why?
|
| Th17 Cells | 4 | 2021 | 97 | 0.390 |
Why?
|
| Streptococcus | 5 | 2020 | 64 | 0.390 |
Why?
|
| Nasal Cavity | 3 | 2019 | 56 | 0.390 |
Why?
|
| Malnutrition | 1 | 2015 | 157 | 0.380 |
Why?
|
| Research | 1 | 2015 | 264 | 0.380 |
Why?
|
| Nasal Mucosa | 3 | 2019 | 88 | 0.380 |
Why?
|
| Enterocolitis, Necrotizing | 4 | 2020 | 256 | 0.380 |
Why?
|
| Anthrax Vaccines | 1 | 2012 | 28 | 0.370 |
Why?
|
| Middle Aged | 38 | 2026 | 28415 | 0.370 |
Why?
|
| Soil Microbiology | 4 | 2016 | 19 | 0.370 |
Why?
|
| High-Throughput Nucleotide Sequencing | 7 | 2021 | 892 | 0.360 |
Why?
|
| Celiac Disease | 2 | 2025 | 73 | 0.360 |
Why?
|
| Bacillus anthracis | 1 | 2012 | 45 | 0.360 |
Why?
|
| Nitrates | 3 | 2019 | 29 | 0.360 |
Why?
|
| RNA, Viral | 3 | 2025 | 499 | 0.360 |
Why?
|
| Cross Reactions | 1 | 2012 | 159 | 0.360 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 761 | 0.350 |
Why?
|
| Immunoglobulin A, Secretory | 2 | 2021 | 19 | 0.340 |
Why?
|
| Colitis | 4 | 2019 | 166 | 0.340 |
Why?
|
| Polymorphism, Genetic | 5 | 2015 | 776 | 0.340 |
Why?
|
| Base Sequence | 12 | 2018 | 2734 | 0.330 |
Why?
|
| Rotavirus Infections | 3 | 2020 | 282 | 0.330 |
Why?
|
| Moraxella | 6 | 2020 | 14 | 0.330 |
Why?
|
| Diet, High-Fat | 4 | 2022 | 269 | 0.330 |
Why?
|
| Case-Control Studies | 13 | 2026 | 3355 | 0.330 |
Why?
|
| Irritable Bowel Syndrome | 3 | 2020 | 216 | 0.330 |
Why?
|
| Fasting | 3 | 2021 | 304 | 0.330 |
Why?
|
| Staphylococcus | 5 | 2019 | 68 | 0.320 |
Why?
|
| Antigens, Bacterial | 1 | 2012 | 318 | 0.320 |
Why?
|
| Clostridium Infections | 3 | 2018 | 248 | 0.320 |
Why?
|
| Mexican Americans | 3 | 2021 | 162 | 0.320 |
Why?
|
| Ethanol | 4 | 2021 | 168 | 0.310 |
Why?
|
| Hypertension | 4 | 2022 | 1347 | 0.310 |
Why?
|
| Mutation | 6 | 2025 | 6093 | 0.310 |
Why?
|
| Lung Neoplasms | 3 | 2025 | 1547 | 0.310 |
Why?
|
| Hypersensitivity | 2 | 2024 | 226 | 0.310 |
Why?
|
| Milk, Human | 4 | 2020 | 318 | 0.310 |
Why?
|
| Molecular Sequence Data | 15 | 2015 | 3470 | 0.300 |
Why?
|
| Cystic Fibrosis | 4 | 2013 | 266 | 0.300 |
Why?
|
| Escherichia coli Proteins | 6 | 2020 | 315 | 0.300 |
Why?
|
| DNA, Ribosomal | 7 | 2021 | 49 | 0.290 |
Why?
|
| Interleukin-17 | 4 | 2023 | 125 | 0.290 |
Why?
|
| Blood Pressure | 6 | 2022 | 1342 | 0.290 |
Why?
|
| Rhinovirus | 3 | 2018 | 67 | 0.290 |
Why?
|
| Sputum | 4 | 2013 | 115 | 0.280 |
Why?
|
| Polysaccharides | 3 | 2020 | 146 | 0.280 |
Why?
|
| Dietary Fiber | 2 | 2021 | 77 | 0.280 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2021 | 144 | 0.280 |
Why?
|
| Tongue | 3 | 2019 | 28 | 0.280 |
Why?
|
| Child, Preschool | 17 | 2025 | 14989 | 0.280 |
Why?
|
| Young Adult | 18 | 2025 | 10015 | 0.280 |
Why?
|
| Infant, Newborn | 12 | 2025 | 8546 | 0.280 |
Why?
|
| Caliciviridae Infections | 2 | 2025 | 286 | 0.280 |
Why?
|
| DNA, Ribosomal Spacer | 2 | 2018 | 7 | 0.280 |
Why?
|
| RNA, Ribosomal, 18S | 2 | 2018 | 20 | 0.270 |
Why?
|
| Cross-Sectional Studies | 11 | 2025 | 3797 | 0.270 |
Why?
|
| Viral Load | 3 | 2025 | 407 | 0.260 |
Why?
|
| Colonic Neoplasms | 2 | 2021 | 263 | 0.260 |
Why?
|
| Haemophilus | 4 | 2020 | 13 | 0.260 |
Why?
|
| Antimicrobial Cationic Peptides | 2 | 2017 | 37 | 0.250 |
Why?
|
| Saliva | 4 | 2026 | 126 | 0.250 |
Why?
|
| Plasmids | 6 | 2012 | 446 | 0.250 |
Why?
|
| Picornaviridae Infections | 2 | 2018 | 49 | 0.250 |
Why?
|
| alpha-Macroglobulins | 2 | 2016 | 5 | 0.250 |
Why?
|
| Vancomycin | 3 | 2018 | 223 | 0.250 |
Why?
|
| Neonatal Sepsis | 2 | 2017 | 39 | 0.250 |
Why?
|
| Respiratory Sounds | 2 | 2019 | 78 | 0.250 |
Why?
|
| Methylmercury Compounds | 2 | 2016 | 4 | 0.240 |
Why?
|
| Oncogenic Viruses | 1 | 2026 | 22 | 0.240 |
Why?
|
| Chemical and Drug Induced Liver Injury | 2 | 2021 | 150 | 0.240 |
Why?
|
| Child | 22 | 2025 | 26175 | 0.240 |
Why?
|
| Autoantibodies | 6 | 2025 | 440 | 0.240 |
Why?
|
| Homeostasis | 4 | 2025 | 713 | 0.240 |
Why?
|
| Otitis Media | 2 | 2016 | 88 | 0.230 |
Why?
|
| Food Microbiology | 2 | 2018 | 23 | 0.230 |
Why?
|
| Immunotherapy | 3 | 2021 | 760 | 0.230 |
Why?
|
| Autoimmune Diseases | 2 | 2019 | 265 | 0.230 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2017 | 609 | 0.230 |
Why?
|
| Genetic Variation | 6 | 2021 | 1542 | 0.230 |
Why?
|
| Pancreatic Neoplasms | 2 | 2023 | 736 | 0.230 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2022 | 747 | 0.230 |
Why?
|
| Viruses | 3 | 2021 | 115 | 0.230 |
Why?
|
| Urinary Tract Infections | 3 | 2021 | 331 | 0.230 |
Why?
|
| Pilot Projects | 5 | 2025 | 1447 | 0.230 |
Why?
|
| Measles virus | 1 | 2025 | 16 | 0.230 |
Why?
|
| Biomarkers | 8 | 2025 | 3386 | 0.230 |
Why?
|
| Metabolomics | 6 | 2024 | 501 | 0.230 |
Why?
|
| Genes, rRNA | 4 | 2019 | 19 | 0.220 |
Why?
|
| Tryptophan | 2 | 2022 | 83 | 0.220 |
Why?
|
| Bile Acids and Salts | 2 | 2025 | 260 | 0.220 |
Why?
|
| Lymphoid Tissue | 1 | 2025 | 48 | 0.220 |
Why?
|
| Menopause | 1 | 2025 | 85 | 0.220 |
Why?
|
| Tumor Microenvironment | 3 | 2024 | 709 | 0.220 |
Why?
|
| Gene Expression Regulation, Bacterial | 5 | 2013 | 168 | 0.220 |
Why?
|
| Measles | 1 | 2025 | 39 | 0.220 |
Why?
|
| Dairy Products | 1 | 2025 | 42 | 0.220 |
Why?
|
| Proteobacteria | 4 | 2020 | 16 | 0.220 |
Why?
|
| Smoke | 1 | 2025 | 79 | 0.220 |
Why?
|
| Inflammation Mediators | 4 | 2020 | 228 | 0.220 |
Why?
|
| Aging | 4 | 2022 | 1244 | 0.220 |
Why?
|
| Bacteroides thetaiotaomicron | 1 | 2024 | 8 | 0.220 |
Why?
|
| Bacteria, Anaerobic | 1 | 2024 | 8 | 0.220 |
Why?
|
| Infant, Premature, Diseases | 2 | 2017 | 251 | 0.220 |
Why?
|
| Asthma | 3 | 2024 | 922 | 0.220 |
Why?
|
| Glutens | 2 | 2025 | 11 | 0.210 |
Why?
|
| Gene Rearrangement | 1 | 2006 | 322 | 0.210 |
Why?
|
| Melanoma | 3 | 2021 | 927 | 0.210 |
Why?
|
| Conjunctiva | 2 | 2017 | 196 | 0.210 |
Why?
|
| Cadaver | 2 | 2015 | 120 | 0.210 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2025 | 60 | 0.210 |
Why?
|
| Dextran Sulfate | 4 | 2019 | 48 | 0.210 |
Why?
|
| Cohort Studies | 8 | 2025 | 5049 | 0.210 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2025 | 175 | 0.210 |
Why?
|
| Genes, Bacterial | 6 | 2017 | 215 | 0.210 |
Why?
|
| Cigarette Smoking | 1 | 2025 | 91 | 0.210 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2024 | 60 | 0.200 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2021 | 239 | 0.200 |
Why?
|
| Bacillus | 2 | 2018 | 36 | 0.200 |
Why?
|
| HIV Infections | 3 | 2022 | 2036 | 0.200 |
Why?
|
| Texas | 7 | 2026 | 3648 | 0.200 |
Why?
|
| Liver Diseases, Alcoholic | 2 | 2016 | 62 | 0.200 |
Why?
|
| Personality | 1 | 2025 | 110 | 0.200 |
Why?
|
| Chemoradiotherapy | 2 | 2022 | 123 | 0.200 |
Why?
|
| Poliovirus | 1 | 2023 | 47 | 0.200 |
Why?
|
| Aged | 19 | 2025 | 20899 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 57 | 0.200 |
Why?
|
| Computational Biology | 6 | 2019 | 863 | 0.190 |
Why?
|
| Fusobacterium nucleatum | 2 | 2017 | 19 | 0.190 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2023 | 45 | 0.190 |
Why?
|
| Pregnancy | 10 | 2024 | 7403 | 0.190 |
Why?
|
| Ileum | 2 | 2021 | 109 | 0.190 |
Why?
|
| Synbiotics | 1 | 2022 | 5 | 0.190 |
Why?
|
| Adenocarcinoma | 2 | 2022 | 966 | 0.190 |
Why?
|
| Ruminococcus | 2 | 2021 | 11 | 0.190 |
Why?
|
| Caffeine | 1 | 2023 | 66 | 0.190 |
Why?
|
| Nitrosamines | 1 | 2022 | 15 | 0.190 |
Why?
|
| Carcinogenesis | 2 | 2017 | 336 | 0.190 |
Why?
|
| Memory Disorders | 1 | 2024 | 201 | 0.190 |
Why?
|
| Trans Fatty Acids | 1 | 2022 | 12 | 0.190 |
Why?
|
| Lactobacillus | 5 | 2023 | 41 | 0.180 |
Why?
|
| Dinoprostone | 1 | 2022 | 65 | 0.180 |
Why?
|
| Intestine, Small | 2 | 2021 | 290 | 0.180 |
Why?
|
| Bacteroidetes | 3 | 2019 | 21 | 0.180 |
Why?
|
| Evolution, Molecular | 4 | 2007 | 645 | 0.180 |
Why?
|
| Child Development | 1 | 2025 | 267 | 0.180 |
Why?
|
| Lung | 5 | 2025 | 1537 | 0.180 |
Why?
|
| Nose | 2 | 2020 | 114 | 0.180 |
Why?
|
| Bacteroides | 2 | 2020 | 36 | 0.180 |
Why?
|
| Rotavirus | 3 | 2020 | 367 | 0.180 |
Why?
|
| Personality Disorders | 1 | 2025 | 175 | 0.180 |
Why?
|
| Norovirus | 1 | 2025 | 284 | 0.180 |
Why?
|
| Clostridium | 3 | 2018 | 17 | 0.180 |
Why?
|
| Cryptosporidium | 1 | 2022 | 27 | 0.180 |
Why?
|
| Anus Neoplasms | 1 | 2022 | 40 | 0.180 |
Why?
|
| Liver Diseases | 1 | 2026 | 378 | 0.180 |
Why?
|
| Cryptosporidium parvum | 1 | 2022 | 21 | 0.180 |
Why?
|
| Cryptosporidiosis | 1 | 2022 | 35 | 0.180 |
Why?
|
| Carotenoids | 1 | 2022 | 77 | 0.180 |
Why?
|
| Kinetics | 2 | 2021 | 1083 | 0.170 |
Why?
|
| Cluster Analysis | 6 | 2019 | 412 | 0.170 |
Why?
|
| Verrucomicrobia | 1 | 2021 | 18 | 0.170 |
Why?
|
| Diarrhea | 2 | 2015 | 316 | 0.170 |
Why?
|
| Transcriptome | 4 | 2023 | 1111 | 0.170 |
Why?
|
| Immune Evasion | 1 | 2021 | 38 | 0.170 |
Why?
|
| Anxiety | 4 | 2024 | 1007 | 0.170 |
Why?
|
| Candida | 2 | 2022 | 79 | 0.170 |
Why?
|
| Prevotella | 2 | 2018 | 9 | 0.170 |
Why?
|
| beta-Lactamase Inhibitors | 2 | 1999 | 61 | 0.170 |
Why?
|
| Culture Media | 1 | 2021 | 169 | 0.170 |
Why?
|
| CTLA-4 Antigen | 1 | 2021 | 65 | 0.170 |
Why?
|
| Streptococcus gallolyticus subspecies gallolyticus | 1 | 2021 | 2 | 0.170 |
Why?
|
| Coenzyme A-Transferases | 1 | 2021 | 1 | 0.170 |
Why?
|
| Type VII Secretion Systems | 1 | 2021 | 2 | 0.170 |
Why?
|
| Mars | 1 | 2021 | 2 | 0.170 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2021 | 78 | 0.170 |
Why?
|
| Tooth Loss | 1 | 2020 | 4 | 0.170 |
Why?
|
| Goblet Cells | 2 | 2020 | 105 | 0.170 |
Why?
|
| Floods | 1 | 2021 | 21 | 0.170 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2020 | 19 | 0.160 |
Why?
|
| Rats, Inbred WKY | 4 | 2022 | 41 | 0.160 |
Why?
|
| Rats, Inbred SHR | 4 | 2022 | 52 | 0.160 |
Why?
|
| Biological Evolution | 2 | 2015 | 220 | 0.160 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 275 | 0.160 |
Why?
|
| Periodontal Diseases | 1 | 2020 | 31 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 4 | 2020 | 978 | 0.160 |
Why?
|
| Adolescent | 15 | 2025 | 20774 | 0.160 |
Why?
|
| Respiratory Syncytial Viruses | 2 | 2018 | 153 | 0.160 |
Why?
|
| Oxidoreductases | 2 | 2017 | 104 | 0.160 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2024 | 231 | 0.160 |
Why?
|
| Insulin-Secreting Cells | 2 | 2019 | 134 | 0.160 |
Why?
|
| Virulence Factors | 2 | 2020 | 181 | 0.160 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2020 | 33 | 0.160 |
Why?
|
| Cervix Uteri | 1 | 2020 | 57 | 0.160 |
Why?
|
| Bacterial Adhesion | 1 | 2020 | 104 | 0.160 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2020 | 43 | 0.160 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 154 | 0.160 |
Why?
|
| Cyclonic Storms | 1 | 2021 | 75 | 0.150 |
Why?
|
| Astronauts | 1 | 2021 | 82 | 0.150 |
Why?
|
| Disasters | 1 | 2021 | 101 | 0.150 |
Why?
|
| Respiratory Tract Infections | 2 | 2020 | 297 | 0.150 |
Why?
|
| Bronchiolitis, Viral | 2 | 2017 | 29 | 0.150 |
Why?
|
| Lactose | 2 | 2018 | 55 | 0.150 |
Why?
|
| Pediatric Obesity | 1 | 2025 | 413 | 0.150 |
Why?
|
| Species Specificity | 5 | 2022 | 473 | 0.150 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2021 | 526 | 0.150 |
Why?
|
| Databases, Genetic | 3 | 2018 | 500 | 0.150 |
Why?
|
| Pharynx | 2 | 2016 | 65 | 0.150 |
Why?
|
| Siblings | 2 | 2018 | 202 | 0.150 |
Why?
|
| Dietary Fats | 2 | 2022 | 275 | 0.150 |
Why?
|
| Colorectal Neoplasms | 2 | 2017 | 620 | 0.150 |
Why?
|
| Enzyme Inhibitors | 2 | 1999 | 559 | 0.150 |
Why?
|
| Social Behavior | 2 | 2022 | 213 | 0.150 |
Why?
|
| Linear Models | 2 | 2020 | 686 | 0.150 |
Why?
|
| Hypotension | 1 | 2021 | 182 | 0.150 |
Why?
|
| Immunoglobulin A | 2 | 2017 | 205 | 0.150 |
Why?
|
| Rest | 1 | 2019 | 64 | 0.150 |
Why?
|
| Paraffin Embedding | 1 | 2019 | 40 | 0.150 |
Why?
|
| Bacterial Translocation | 2 | 2017 | 24 | 0.150 |
Why?
|
| DNA Probes | 2 | 2016 | 118 | 0.150 |
Why?
|
| Microbial Consortia | 2 | 2015 | 6 | 0.140 |
Why?
|
| Formaldehyde | 1 | 2019 | 50 | 0.140 |
Why?
|
| Chlorhexidine | 1 | 2019 | 48 | 0.140 |
Why?
|
| Overweight | 2 | 2019 | 376 | 0.140 |
Why?
|
| Immunity, Mucosal | 2 | 2017 | 97 | 0.140 |
Why?
|
| Intestinal Perforation | 1 | 2019 | 51 | 0.140 |
Why?
|
| Circadian Clocks | 1 | 2020 | 87 | 0.140 |
Why?
|
| Aspartic Acid | 1 | 1999 | 72 | 0.140 |
Why?
|
| Enema | 1 | 2018 | 44 | 0.140 |
Why?
|
| High Fructose Corn Syrup | 1 | 2018 | 6 | 0.140 |
Why?
|
| Colonic Polyps | 1 | 2019 | 81 | 0.140 |
Why?
|
| Bifidobacterium | 4 | 2020 | 65 | 0.140 |
Why?
|
| Gammaproteobacteria | 1 | 2018 | 14 | 0.140 |
Why?
|
| Fusobacterium | 1 | 2018 | 3 | 0.140 |
Why?
|
| Phenylalanine | 1 | 1999 | 131 | 0.140 |
Why?
|
| Acetates | 1 | 2018 | 77 | 0.140 |
Why?
|
| Brain Injuries | 1 | 2023 | 702 | 0.140 |
Why?
|
| Clostridiaceae | 1 | 2018 | 5 | 0.140 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 404 | 0.140 |
Why?
|
| Germ-Free Life | 4 | 2021 | 61 | 0.140 |
Why?
|
| Streptococcal Infections | 1 | 2021 | 254 | 0.140 |
Why?
|
| Saccharomyces | 1 | 2017 | 9 | 0.140 |
Why?
|
| Cognition | 2 | 2020 | 817 | 0.140 |
Why?
|
| Micronutrients | 2 | 2022 | 61 | 0.140 |
Why?
|
| Malassezia | 1 | 2017 | 6 | 0.140 |
Why?
|
| Crohn Disease | 2 | 2021 | 290 | 0.140 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 338 | 0.130 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2018 | 44 | 0.130 |
Why?
|
| Acculturation | 1 | 2018 | 61 | 0.130 |
Why?
|
| RNA, Bacterial | 5 | 2017 | 58 | 0.130 |
Why?
|
| Dietary Carbohydrates | 1 | 2018 | 106 | 0.130 |
Why?
|
| Candida albicans | 1 | 2018 | 87 | 0.130 |
Why?
|
| Health Surveys | 1 | 2018 | 257 | 0.130 |
Why?
|
| Environmental Exposure | 2 | 2021 | 292 | 0.130 |
Why?
|
| Fusobacterium Infections | 1 | 2017 | 9 | 0.130 |
Why?
|
| Chemokine CCL20 | 1 | 2017 | 17 | 0.130 |
Why?
|
| Physical Conditioning, Animal | 1 | 2018 | 85 | 0.130 |
Why?
|
| Endotoxins | 1 | 2017 | 51 | 0.130 |
Why?
|
| Space Flight | 1 | 2021 | 177 | 0.130 |
Why?
|
| Leishmania infantum | 1 | 2017 | 3 | 0.130 |
Why?
|
| Orthokeratologic Procedures | 1 | 2017 | 2 | 0.130 |
Why?
|
| Spondylarthritis | 1 | 2017 | 8 | 0.130 |
Why?
|
| Psychodidae | 1 | 2017 | 14 | 0.130 |
Why?
|
| Sphingolipids | 1 | 2017 | 36 | 0.130 |
Why?
|
| Time Factors | 8 | 2021 | 6215 | 0.130 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2026 | 971 | 0.130 |
Why?
|
| Contact Lenses, Hydrophilic | 1 | 2017 | 18 | 0.130 |
Why?
|
| Disease Vectors | 1 | 2017 | 22 | 0.130 |
Why?
|
| Cell Proliferation | 3 | 2021 | 2463 | 0.130 |
Why?
|
| Mental Disorders | 1 | 2025 | 902 | 0.130 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2019 | 191 | 0.130 |
Why?
|
| Rats | 5 | 2022 | 3383 | 0.130 |
Why?
|
| Biliary Atresia | 1 | 2020 | 223 | 0.130 |
Why?
|
| Adaptation, Biological | 2 | 2015 | 31 | 0.130 |
Why?
|
| Genes, Duplicate | 1 | 2016 | 16 | 0.130 |
Why?
|
| Antigens | 1 | 2017 | 104 | 0.120 |
Why?
|
| Ear, Middle | 1 | 2016 | 24 | 0.120 |
Why?
|
| Disease | 1 | 2018 | 121 | 0.120 |
Why?
|
| Travel | 2 | 2015 | 127 | 0.120 |
Why?
|
| Agricultural Irrigation | 1 | 2016 | 2 | 0.120 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2019 | 347 | 0.120 |
Why?
|
| Vitamin D | 1 | 2018 | 196 | 0.120 |
Why?
|
| Uveitis | 1 | 2017 | 33 | 0.120 |
Why?
|
| Macrophages | 1 | 2021 | 661 | 0.120 |
Why?
|
| Risk Factors | 9 | 2025 | 10967 | 0.120 |
Why?
|
| N-Acetylmuramoyl-L-alanine Amidase | 2 | 2009 | 6 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 878 | 0.120 |
Why?
|
| Pregnancy Complications | 1 | 2021 | 542 | 0.120 |
Why?
|
| Soil Pollutants | 1 | 2016 | 13 | 0.120 |
Why?
|
| Nerve Net | 1 | 2019 | 259 | 0.120 |
Why?
|
| Oryza | 1 | 2016 | 28 | 0.120 |
Why?
|
| Cresols | 1 | 2016 | 10 | 0.120 |
Why?
|
| Anastomotic Leak | 1 | 2016 | 36 | 0.120 |
Why?
|
| Staphylococcus aureus | 2 | 2012 | 478 | 0.120 |
Why?
|
| Enterococcus faecalis | 1 | 2016 | 50 | 0.120 |
Why?
|
| Morphine | 1 | 2016 | 80 | 0.120 |
Why?
|
| Eye Infections, Bacterial | 1 | 2017 | 81 | 0.120 |
Why?
|
| Mitochondrial Diseases | 1 | 2018 | 152 | 0.120 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2016 | 32 | 0.120 |
Why?
|
| Sulfuric Acid Esters | 1 | 2016 | 15 | 0.120 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 1804 | 0.120 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 448 | 0.120 |
Why?
|
| Lactates | 1 | 2016 | 81 | 0.120 |
Why?
|
| Mucor | 1 | 2015 | 1 | 0.120 |
Why?
|
| Mouth Mucosa | 1 | 2016 | 45 | 0.120 |
Why?
|
| Cyprinodontiformes | 1 | 2015 | 2 | 0.120 |
Why?
|
| Salmonella Infections, Animal | 1 | 2015 | 6 | 0.120 |
Why?
|
| Occupational Exposure | 1 | 2017 | 137 | 0.120 |
Why?
|
| DNA Transposable Elements | 2 | 2007 | 179 | 0.120 |
Why?
|
| Gestational Age | 2 | 2017 | 1209 | 0.120 |
Why?
|
| Genome, Fungal | 1 | 2015 | 33 | 0.120 |
Why?
|
| Stress, Psychological | 1 | 2021 | 538 | 0.120 |
Why?
|
| Induction Chemotherapy | 1 | 2016 | 55 | 0.120 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 337 | 0.120 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2016 | 84 | 0.120 |
Why?
|
| Major Histocompatibility Complex | 1 | 2015 | 48 | 0.120 |
Why?
|
| Enteral Nutrition | 1 | 2018 | 286 | 0.120 |
Why?
|
| Phenotype | 5 | 2018 | 4478 | 0.110 |
Why?
|
| Liver | 3 | 2025 | 1789 | 0.110 |
Why?
|
| Liver Neoplasms | 1 | 2026 | 1362 | 0.110 |
Why?
|
| Antibiosis | 1 | 2015 | 14 | 0.110 |
Why?
|
| Mucormycosis | 1 | 2015 | 32 | 0.110 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2015 | 82 | 0.110 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 5164 | 0.110 |
Why?
|
| Opportunistic Infections | 1 | 2015 | 72 | 0.110 |
Why?
|
| Arginine | 1 | 2018 | 337 | 0.110 |
Why?
|
| Sodium Compounds | 1 | 2015 | 9 | 0.110 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 398 | 0.110 |
Why?
|
| Severity of Illness Index | 6 | 2022 | 3031 | 0.110 |
Why?
|
| Equipment Design | 1 | 2017 | 536 | 0.110 |
Why?
|
| Psoriasis | 1 | 2015 | 48 | 0.110 |
Why?
|
| Monocytes | 1 | 2017 | 336 | 0.110 |
Why?
|
| Arsenites | 1 | 2015 | 18 | 0.110 |
Why?
|
| Enteritis | 1 | 2015 | 53 | 0.110 |
Why?
|
| Nitric Oxide | 2 | 2018 | 465 | 0.110 |
Why?
|
| Urinary Catheters | 1 | 2015 | 26 | 0.110 |
Why?
|
| Staphylococcal Infections | 2 | 2012 | 563 | 0.110 |
Why?
|
| Polymyxin B | 1 | 2015 | 44 | 0.110 |
Why?
|
| Postmortem Changes | 1 | 2014 | 11 | 0.110 |
Why?
|
| Serotonin | 1 | 2016 | 205 | 0.110 |
Why?
|
| Tissue Donors | 3 | 2025 | 501 | 0.110 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2018 | 239 | 0.110 |
Why?
|
| Enterocytes | 2 | 2012 | 68 | 0.110 |
Why?
|
| Inpatients | 3 | 2025 | 559 | 0.110 |
Why?
|
| Blood Glucose | 4 | 2022 | 1109 | 0.110 |
Why?
|
| Fetal Blood | 1 | 2015 | 179 | 0.110 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 683 | 0.110 |
Why?
|
| Colitis, Ulcerative | 1 | 2017 | 208 | 0.110 |
Why?
|
| Open Reading Frames | 5 | 2021 | 200 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 995 | 0.110 |
Why?
|
| Sjogren's Syndrome | 1 | 2016 | 108 | 0.110 |
Why?
|
| Disease Progression | 5 | 2024 | 2193 | 0.110 |
Why?
|
| Disease Susceptibility | 4 | 2019 | 278 | 0.110 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2015 | 91 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2017 | 328 | 0.110 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2015 | 70 | 0.100 |
Why?
|
| Neoplasms | 3 | 2020 | 2985 | 0.100 |
Why?
|
| Streptococcus agalactiae | 1 | 2015 | 106 | 0.100 |
Why?
|
| Cities | 2 | 2024 | 51 | 0.100 |
Why?
|
| Nasopharyngitis | 1 | 2013 | 6 | 0.100 |
Why?
|
| Rabbits | 2 | 2012 | 574 | 0.100 |
Why?
|
| Enterotoxigenic Escherichia coli | 1 | 2013 | 7 | 0.100 |
Why?
|
| Stroke | 1 | 2022 | 1060 | 0.100 |
Why?
|
| Computer Simulation | 1 | 2017 | 671 | 0.100 |
Why?
|
| Cloning, Molecular | 2 | 2012 | 780 | 0.100 |
Why?
|
| Urinary Bladder | 1 | 2015 | 219 | 0.100 |
Why?
|
| Body Mass Index | 4 | 2025 | 1679 | 0.100 |
Why?
|
| Mexico | 1 | 2014 | 190 | 0.100 |
Why?
|
| Amino Acid Sequence | 5 | 2002 | 2397 | 0.100 |
Why?
|
| Treatment Outcome | 5 | 2021 | 12865 | 0.100 |
Why?
|
| Transglutaminases | 2 | 2025 | 26 | 0.100 |
Why?
|
| Anxiety Disorders | 1 | 2019 | 726 | 0.100 |
Why?
|
| Virulence | 2 | 2020 | 271 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 3 | 2025 | 253 | 0.100 |
Why?
|
| Glycoside Hydrolases | 1 | 2012 | 16 | 0.100 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 82 | 0.100 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 3717 | 0.100 |
Why?
|
| Ginsenosides | 1 | 2012 | 16 | 0.100 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2013 | 85 | 0.100 |
Why?
|
| Bacterial Toxins | 1 | 2013 | 170 | 0.090 |
Why?
|
| Cell Movement | 2 | 2017 | 875 | 0.090 |
Why?
|
| Organizations | 1 | 2012 | 17 | 0.090 |
Why?
|
| DNA Repair | 3 | 2020 | 570 | 0.090 |
Why?
|
| Enterococcus faecium | 1 | 2012 | 19 | 0.090 |
Why?
|
| Glucose Tolerance Test | 2 | 2025 | 198 | 0.090 |
Why?
|
| Wound Healing | 1 | 2016 | 486 | 0.090 |
Why?
|
| Genetic Vectors | 3 | 2012 | 897 | 0.090 |
Why?
|
| Sleep | 1 | 2015 | 371 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2012 | 100 | 0.090 |
Why?
|
| Internet | 2 | 2012 | 422 | 0.090 |
Why?
|
| DNA Primers | 3 | 2012 | 600 | 0.090 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 4034 | 0.090 |
Why?
|
| Mucins | 2 | 2023 | 71 | 0.090 |
Why?
|
| Prognosis | 3 | 2020 | 4867 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2013 | 360 | 0.090 |
Why?
|
| Administration, Oral | 3 | 2021 | 709 | 0.090 |
Why?
|
| Gene Expression | 2 | 2013 | 1485 | 0.090 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 484 | 0.080 |
Why?
|
| Liver Transplantation | 1 | 2020 | 1129 | 0.080 |
Why?
|
| Discriminant Analysis | 2 | 2021 | 21 | 0.080 |
Why?
|
| Bacteriological Techniques | 1 | 2011 | 87 | 0.080 |
Why?
|
| Macaca mulatta | 1 | 2012 | 492 | 0.080 |
Why?
|
| beta-Lactams | 2 | 2002 | 56 | 0.080 |
Why?
|
| Principal Component Analysis | 3 | 2019 | 151 | 0.080 |
Why?
|
| Frameshift Mutation | 2 | 2009 | 202 | 0.080 |
Why?
|
| Genomic Islands | 2 | 2007 | 29 | 0.080 |
Why?
|
| Autism Spectrum Disorder | 1 | 2016 | 450 | 0.080 |
Why?
|
| Multivariate Analysis | 3 | 2020 | 1375 | 0.080 |
Why?
|
| Incidence | 4 | 2020 | 3320 | 0.080 |
Why?
|
| Nutritional Status | 1 | 2012 | 302 | 0.080 |
Why?
|
| DNA Fingerprinting | 2 | 2008 | 106 | 0.080 |
Why?
|
| Antibodies, Bacterial | 1 | 2012 | 417 | 0.080 |
Why?
|
| Finland | 2 | 2020 | 46 | 0.080 |
Why?
|
| Mutagenesis | 3 | 2004 | 325 | 0.080 |
Why?
|
| Artifacts | 1 | 2011 | 99 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 904 | 0.080 |
Why?
|
| Placenta | 1 | 2014 | 497 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2011 | 261 | 0.080 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2015 | 401 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2024 | 3823 | 0.080 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 2333 | 0.080 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 6800 | 0.080 |
Why?
|
| Depression | 3 | 2024 | 1310 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2022 | 293 | 0.070 |
Why?
|
| Brain | 4 | 2024 | 3170 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2016 | 1081 | 0.070 |
Why?
|
| Food Hypersensitivity | 1 | 2012 | 186 | 0.070 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2009 | 87 | 0.070 |
Why?
|
| Hospitalization | 4 | 2019 | 1939 | 0.070 |
Why?
|
| DNA Mutational Analysis | 2 | 2009 | 778 | 0.070 |
Why?
|
| Cytokines | 3 | 2022 | 1343 | 0.070 |
Why?
|
| Carbon | 1 | 2009 | 99 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2020 | 424 | 0.070 |
Why?
|
| Freezing | 2 | 2020 | 27 | 0.070 |
Why?
|
| Random Allocation | 2 | 2021 | 415 | 0.070 |
Why?
|
| Shewanella | 1 | 2008 | 10 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2015 | 889 | 0.070 |
Why?
|
| Corynebacterium | 2 | 2019 | 13 | 0.070 |
Why?
|
| T-Lymphocytes | 4 | 2021 | 1712 | 0.070 |
Why?
|
| Body Weight | 1 | 2012 | 986 | 0.070 |
Why?
|
| Treponema pallidum | 1 | 2008 | 48 | 0.070 |
Why?
|
| Freeze Drying | 2 | 2018 | 13 | 0.070 |
Why?
|
| Age Factors | 3 | 2020 | 2830 | 0.070 |
Why?
|
| Classification | 2 | 2020 | 17 | 0.070 |
Why?
|
| Cryopreservation | 2 | 2018 | 78 | 0.070 |
Why?
|
| Peptides | 3 | 2023 | 705 | 0.070 |
Why?
|
| Gastroenteritis | 2 | 2025 | 308 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2022 | 637 | 0.070 |
Why?
|
| Cathelicidins | 2 | 2017 | 13 | 0.070 |
Why?
|
| Behavior, Animal | 2 | 2024 | 490 | 0.060 |
Why?
|
| Rats, Long-Evans | 2 | 2018 | 96 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2020 | 196 | 0.060 |
Why?
|
| Life Style | 2 | 2020 | 444 | 0.060 |
Why?
|
| Length of Stay | 3 | 2017 | 1404 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 116 | 0.060 |
Why?
|
| Philippines | 2 | 2016 | 22 | 0.060 |
Why?
|
| Sequence Homology | 1 | 2006 | 58 | 0.060 |
Why?
|
| Breast Feeding | 2 | 2018 | 234 | 0.060 |
Why?
|
| Pseudogenes | 1 | 2006 | 50 | 0.060 |
Why?
|
| Ampicillin Resistance | 2 | 1996 | 18 | 0.060 |
Why?
|
| Health | 2 | 2019 | 35 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2022 | 1621 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2021 | 501 | 0.060 |
Why?
|
| Interleukins | 2 | 2017 | 121 | 0.060 |
Why?
|
| Temperature | 2 | 2020 | 290 | 0.060 |
Why?
|
| Oligonucleotide Probes | 1 | 2025 | 84 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 2 | 2019 | 411 | 0.060 |
Why?
|
| User-Computer Interface | 1 | 2026 | 164 | 0.060 |
Why?
|
| Soil | 2 | 2016 | 76 | 0.060 |
Why?
|
| Cheese | 1 | 2025 | 8 | 0.060 |
Why?
|
| United States | 5 | 2024 | 11883 | 0.060 |
Why?
|
| Yogurt | 1 | 2025 | 13 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2006 | 422 | 0.060 |
Why?
|
| Prevalence | 2 | 2026 | 2688 | 0.060 |
Why?
|
| Peptide Library | 2 | 2008 | 56 | 0.050 |
Why?
|
| Rats, Wistar | 2 | 2016 | 301 | 0.050 |
Why?
|
| Escherichia coli K12 | 1 | 2004 | 3 | 0.050 |
Why?
|
| Livestock | 1 | 2024 | 11 | 0.050 |
Why?
|
| Lipocalin-2 | 1 | 2024 | 31 | 0.050 |
Why?
|
| Colonoscopy | 2 | 2017 | 240 | 0.050 |
Why?
|
| Farmers | 1 | 2024 | 13 | 0.050 |
Why?
|
| Ribotyping | 2 | 2015 | 49 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 2 | 1999 | 851 | 0.050 |
Why?
|
| Birds | 1 | 2024 | 49 | 0.050 |
Why?
|
| Biotransformation | 2 | 2015 | 54 | 0.050 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2007 | 398 | 0.050 |
Why?
|
| Influenza in Birds | 1 | 2024 | 27 | 0.050 |
Why?
|
| Glucose | 2 | 2020 | 851 | 0.050 |
Why?
|
| Capsid Proteins | 1 | 2025 | 148 | 0.050 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 56 | 0.050 |
Why?
|
| Epidemiological Monitoring | 1 | 2024 | 72 | 0.050 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2024 | 10 | 0.050 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2023 | 6 | 0.050 |
Why?
|
| Insulin Antibodies | 1 | 2023 | 7 | 0.050 |
Why?
|
| Ecosystem | 2 | 2015 | 90 | 0.050 |
Why?
|
| Glutamate Decarboxylase | 1 | 2023 | 45 | 0.050 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 679 | 0.050 |
Why?
|
| Point Mutation | 1 | 2004 | 332 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 2101 | 0.050 |
Why?
|
| Cattle | 1 | 2024 | 502 | 0.050 |
Why?
|
| Abdominal Pain | 2 | 2019 | 315 | 0.050 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2023 | 35 | 0.050 |
Why?
|
| Acute Disease | 2 | 2019 | 1154 | 0.050 |
Why?
|
| Coffee | 1 | 2023 | 28 | 0.050 |
Why?
|
| Physical Abuse | 1 | 2023 | 24 | 0.050 |
Why?
|
| Insulin, Regular, Human | 1 | 2022 | 12 | 0.050 |
Why?
|
| Lactic Acid | 1 | 2023 | 147 | 0.050 |
Why?
|
| Growth Inhibitors | 1 | 2022 | 35 | 0.050 |
Why?
|
| Models, Genetic | 3 | 2015 | 748 | 0.050 |
Why?
|
| Propionates | 1 | 2022 | 31 | 0.050 |
Why?
|
| alpha-Tocopherol | 1 | 2022 | 36 | 0.050 |
Why?
|
| Mucus | 1 | 2022 | 37 | 0.050 |
Why?
|
| Ketones | 1 | 2022 | 26 | 0.050 |
Why?
|
| Enterobacter | 1 | 2002 | 13 | 0.050 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2022 | 48 | 0.050 |
Why?
|
| Adenosine Deaminase | 1 | 2022 | 89 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 47 | 0.050 |
Why?
|
| Carcinogens | 1 | 2022 | 128 | 0.050 |
Why?
|
| Kynurenine | 1 | 2022 | 24 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2019 | 3407 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2019 | 2826 | 0.040 |
Why?
|
| Premature Birth | 2 | 2018 | 420 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2021 | 39 | 0.040 |
Why?
|
| Water | 1 | 2023 | 185 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2023 | 315 | 0.040 |
Why?
|
| Nicotine | 1 | 2022 | 116 | 0.040 |
Why?
|
| Calcitriol | 1 | 2021 | 63 | 0.040 |
Why?
|
| Estradiol | 1 | 2023 | 461 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2021 | 78 | 0.040 |
Why?
|
| Laminin | 1 | 2021 | 66 | 0.040 |
Why?
|
| Constipation | 1 | 2022 | 130 | 0.040 |
Why?
|
| Critical Care | 2 | 2017 | 689 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 1806 | 0.040 |
Why?
|
| Oleanolic Acid | 1 | 2021 | 7 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2023 | 273 | 0.040 |
Why?
|
| Cholic Acid | 1 | 2021 | 19 | 0.040 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2021 | 32 | 0.040 |
Why?
|
| Mice, Inbred A | 1 | 2021 | 8 | 0.040 |
Why?
|
| Sociological Factors | 1 | 2021 | 9 | 0.040 |
Why?
|
| Cecum | 1 | 2021 | 26 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2021 | 59 | 0.040 |
Why?
|
| Fructans | 1 | 2020 | 12 | 0.040 |
Why?
|
| Germany | 1 | 2021 | 58 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 448 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2021 | 101 | 0.040 |
Why?
|
| Aerococcaceae | 1 | 2020 | 2 | 0.040 |
Why?
|
| Adhesins, Escherichia coli | 1 | 2020 | 18 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 69 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2021 | 425 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2021 | 156 | 0.040 |
Why?
|
| Fimbriae, Bacterial | 1 | 2020 | 39 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2022 | 288 | 0.040 |
Why?
|
| Public Health | 1 | 2023 | 273 | 0.040 |
Why?
|
| Comamonadaceae | 1 | 2020 | 1 | 0.040 |
Why?
|
| Gardnerella | 1 | 2020 | 2 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2021 | 269 | 0.040 |
Why?
|
| Oral Health | 1 | 2020 | 28 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 2333 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2022 | 412 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 1456 | 0.040 |
Why?
|
| Bifidobacterium longum | 1 | 2020 | 4 | 0.040 |
Why?
|
| Clostridium symbiosum | 1 | 2020 | 4 | 0.040 |
Why?
|
| Faecalibacterium prausnitzii | 1 | 2020 | 6 | 0.040 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2020 | 7 | 0.040 |
Why?
|
| Mucin-4 | 1 | 2020 | 12 | 0.040 |
Why?
|
| Botswana | 1 | 2020 | 76 | 0.040 |
Why?
|
| Mucin-2 | 1 | 2020 | 39 | 0.040 |
Why?
|
| Bile | 1 | 2020 | 44 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 232 | 0.040 |
Why?
|
| Folic Acid | 1 | 2022 | 269 | 0.040 |
Why?
|
| Collagen | 1 | 2021 | 275 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2021 | 228 | 0.040 |
Why?
|
| Preservation, Biological | 1 | 2020 | 10 | 0.040 |
Why?
|
| Diet Surveys | 1 | 2020 | 98 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2020 | 111 | 0.040 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2019 | 21 | 0.040 |
Why?
|
| HLA-DQ Antigens | 1 | 2019 | 22 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 154 | 0.040 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2019 | 43 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2022 | 373 | 0.040 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2020 | 62 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2021 | 731 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 1999 | 85 | 0.040 |
Why?
|
| Intensive Care, Neonatal | 1 | 2019 | 55 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2020 | 273 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 287 | 0.040 |
Why?
|
| Vegetables | 1 | 2021 | 266 | 0.040 |
Why?
|
| Food Analysis | 1 | 2019 | 23 | 0.040 |
Why?
|
| Primary Prevention | 1 | 2021 | 182 | 0.040 |
Why?
|
| Leukocytes | 1 | 2020 | 207 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 2019 | 48 | 0.040 |
Why?
|
| Mouthwashes | 1 | 2019 | 10 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2019 | 157 | 0.040 |
Why?
|
| Immune System | 1 | 2020 | 100 | 0.040 |
Why?
|
| Drug Resistance, Microbial | 1 | 1999 | 195 | 0.040 |
Why?
|
| Streptomyces | 1 | 1999 | 13 | 0.040 |
Why?
|
| Gram-Positive Bacteria | 1 | 2019 | 44 | 0.040 |
Why?
|
| Hippocampus | 1 | 2024 | 797 | 0.040 |
Why?
|
| Positive-Pressure Respiration | 1 | 2019 | 84 | 0.040 |
Why?
|
| Virus Replication | 1 | 2022 | 607 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2020 | 590 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2021 | 410 | 0.040 |
Why?
|
| Bacteriophage M13 | 1 | 1998 | 17 | 0.040 |
Why?
|
| Capsules | 1 | 2018 | 21 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2020 | 167 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2019 | 141 | 0.040 |
Why?
|
| Fever | 1 | 2021 | 313 | 0.040 |
Why?
|
| Pets | 1 | 2018 | 20 | 0.040 |
Why?
|
| Models, Molecular | 2 | 1999 | 1061 | 0.040 |
Why?
|
| Virus Diseases | 1 | 2021 | 287 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 320 | 0.040 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2019 | 127 | 0.040 |
Why?
|
| Protein Engineering | 1 | 1998 | 62 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 724 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2018 | 98 | 0.030 |
Why?
|
| Rotavirus Vaccines | 1 | 2018 | 62 | 0.030 |
Why?
|
| Neomycin | 1 | 2018 | 36 | 0.030 |
Why?
|
| Streptomycin | 1 | 2018 | 12 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2018 | 25 | 0.030 |
Why?
|
| Catalysis | 1 | 1998 | 138 | 0.030 |
Why?
|
| Colombia | 1 | 2018 | 51 | 0.030 |
Why?
|
| Animal Feed | 1 | 2018 | 79 | 0.030 |
Why?
|
| Individuality | 1 | 2018 | 37 | 0.030 |
Why?
|
| Influenza, Human | 1 | 2024 | 704 | 0.030 |
Why?
|
| Glucose Clamp Technique | 1 | 2018 | 75 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1999 | 313 | 0.030 |
Why?
|
| Ornithine | 1 | 2018 | 31 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 1996 | 553 | 0.030 |
Why?
|
| Common Cold | 1 | 2017 | 24 | 0.030 |
Why?
|
| Raffinose | 1 | 2017 | 7 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2023 | 4669 | 0.030 |
Why?
|
| Australia | 1 | 2018 | 171 | 0.030 |
Why?
|
| Animal Technicians | 1 | 2017 | 4 | 0.030 |
Why?
|
| Acetic Acid | 1 | 2017 | 17 | 0.030 |
Why?
|
| Medical Laboratory Personnel | 1 | 2017 | 14 | 0.030 |
Why?
|
| Haemophilus influenzae | 1 | 2018 | 134 | 0.030 |
Why?
|
| Family | 1 | 2021 | 586 | 0.030 |
Why?
|
| Sucrose | 1 | 2017 | 37 | 0.030 |
Why?
|
| Air Pollutants, Occupational | 1 | 2017 | 24 | 0.030 |
Why?
|
| New York | 1 | 2017 | 69 | 0.030 |
Why?
|
| Memory | 1 | 2020 | 352 | 0.030 |
Why?
|
| Cell Line | 1 | 2022 | 2558 | 0.030 |
Why?
|
| Interleukin-23 | 1 | 2017 | 16 | 0.030 |
Why?
|
| HIV-1 | 1 | 2021 | 493 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2017 | 66 | 0.030 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2017 | 62 | 0.030 |
Why?
|
| Joints | 1 | 2017 | 25 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 106 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2017 | 53 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2019 | 582 | 0.030 |
Why?
|
| Age of Onset | 1 | 2018 | 597 | 0.030 |
Why?
|
| Linoleic Acid | 1 | 2016 | 20 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1244 | 0.030 |
Why?
|
| Population Groups | 1 | 2016 | 31 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 372 | 0.030 |
Why?
|
| Rectum | 1 | 2017 | 101 | 0.030 |
Why?
|
| Collagenases | 1 | 2016 | 15 | 0.030 |
Why?
|
| Otoscopy | 1 | 2016 | 13 | 0.030 |
Why?
|
| Food Contamination | 1 | 2016 | 29 | 0.030 |
Why?
|
| Remission Induction | 1 | 2017 | 306 | 0.030 |
Why?
|
| Systole | 1 | 2016 | 195 | 0.030 |
Why?
|
| Housing, Animal | 1 | 2016 | 18 | 0.030 |
Why?
|
| Agriculture | 1 | 2016 | 30 | 0.030 |
Why?
|
| Mercury | 1 | 2016 | 31 | 0.030 |
Why?
|
| Louisiana | 1 | 2016 | 137 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2022 | 801 | 0.030 |
Why?
|
| Ventral Tegmental Area | 1 | 2016 | 48 | 0.030 |
Why?
|
| Ampicillin | 1 | 1996 | 59 | 0.030 |
Why?
|
| Nitrogen Cycle | 1 | 2015 | 2 | 0.030 |
Why?
|
| Epithelium | 1 | 2017 | 336 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2017 | 331 | 0.030 |
Why?
|
| Biodegradation, Environmental | 1 | 2015 | 13 | 0.030 |
Why?
|
| Chemotherapy-Induced Febrile Neutropenia | 1 | 2015 | 2 | 0.030 |
Why?
|
| Lyases | 1 | 2015 | 12 | 0.030 |
Why?
|
| Salmonella enterica | 1 | 2015 | 9 | 0.030 |
Why?
|
| Fish Diseases | 1 | 2015 | 7 | 0.030 |
Why?
|
| Hair | 1 | 2015 | 30 | 0.030 |
Why?
|
| Myopia | 1 | 2017 | 121 | 0.030 |
Why?
|
| Onychomycosis | 1 | 2015 | 8 | 0.030 |
Why?
|
| Oxytocin | 1 | 2016 | 68 | 0.030 |
Why?
|
| Fungemia | 1 | 2015 | 22 | 0.030 |
Why?
|
| Emigrants and Immigrants | 1 | 2018 | 169 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2018 | 233 | 0.030 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2015 | 16 | 0.030 |
Why?
|
| Aminoquinolines | 1 | 2015 | 34 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2017 | 187 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 300 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1996 | 285 | 0.030 |
Why?
|
| Ceftazidime | 1 | 1996 | 47 | 0.030 |
Why?
|
| Coinfection | 1 | 2017 | 186 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1157 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2015 | 122 | 0.030 |
Why?
|
| Ultraviolet Rays | 2 | 2007 | 192 | 0.030 |
Why?
|
| Cephalosporins | 1 | 1996 | 135 | 0.030 |
Why?
|
| Symbiosis | 1 | 2015 | 71 | 0.030 |
Why?
|
| Penicillins | 1 | 1996 | 153 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 1484 | 0.030 |
Why?
|
| Streptococcus pneumoniae | 1 | 2018 | 389 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2015 | 37 | 0.030 |
Why?
|
| Urine | 1 | 2015 | 89 | 0.030 |
Why?
|
| Ontario | 1 | 2015 | 84 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2015 | 115 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 2015 | 136 | 0.030 |
Why?
|
| Nitrogen Oxides | 1 | 2014 | 5 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 2015 | 80 | 0.030 |
Why?
|
| Serogroup | 1 | 2015 | 63 | 0.030 |
Why?
|
| Diptera | 1 | 2014 | 19 | 0.030 |
Why?
|
| Protein Binding | 1 | 1999 | 1656 | 0.030 |
Why?
|
| Cross Infection | 1 | 2018 | 334 | 0.030 |
Why?
|
| Urinary Catheterization | 1 | 2015 | 71 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2015 | 238 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2014 | 32 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 1184 | 0.030 |
Why?
|
| Polysomnography | 1 | 2015 | 155 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 1272 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2015 | 154 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 834 | 0.030 |
Why?
|
| Anaerobiosis | 1 | 2014 | 14 | 0.030 |
Why?
|
| Maternal Exposure | 1 | 2015 | 149 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 2114 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 2015 | 141 | 0.030 |
Why?
|
| Nitrites | 1 | 2014 | 48 | 0.030 |
Why?
|
| Bacteroides fragilis | 1 | 2013 | 6 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2022 | 1586 | 0.030 |
Why?
|
| Organ Size | 1 | 2015 | 410 | 0.030 |
Why?
|
| Pregnancy Trimester, First | 1 | 2014 | 115 | 0.030 |
Why?
|
| Genes, Reporter | 2 | 2004 | 341 | 0.030 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 140 | 0.020 |
Why?
|
| Neutropenia | 1 | 2015 | 210 | 0.020 |
Why?
|
| Retina | 1 | 2017 | 433 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2016 | 1210 | 0.020 |
Why?
|
| Binding Sites | 1 | 1996 | 1136 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 1280 | 0.020 |
Why?
|
| Biofilms | 1 | 2014 | 92 | 0.020 |
Why?
|
| Triglycerides | 1 | 2016 | 602 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2017 | 526 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2015 | 290 | 0.020 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2013 | 17 | 0.020 |
Why?
|
| Claudin-1 | 1 | 2013 | 19 | 0.020 |
Why?
|
| Heterozygote | 1 | 2015 | 725 | 0.020 |
Why?
|
| Panax | 1 | 2012 | 7 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 434 | 0.020 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2012 | 20 | 0.020 |
Why?
|
| Recurrence | 1 | 2017 | 1478 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 564 | 0.020 |
Why?
|
| Caco-2 Cells | 1 | 2012 | 86 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2012 | 140 | 0.020 |
Why?
|
| Biological Availability | 1 | 2012 | 137 | 0.020 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2013 | 69 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 263 | 0.020 |
Why?
|
| Thinness | 1 | 2012 | 71 | 0.020 |
Why?
|
| Dry Eye Syndromes | 1 | 2016 | 295 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2013 | 409 | 0.020 |
Why?
|
| Food | 1 | 2012 | 121 | 0.020 |
Why?
|
| Multigene Family | 2 | 2007 | 289 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2012 | 153 | 0.020 |
Why?
|
| Refrigeration | 1 | 2011 | 10 | 0.020 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2011 | 15 | 0.020 |
Why?
|
| Haemophilus parainfluenzae | 1 | 2011 | 11 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 2901 | 0.020 |
Why?
|
| Programming Languages | 1 | 2011 | 17 | 0.020 |
Why?
|
| Anaphylaxis | 1 | 2012 | 93 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2012 | 222 | 0.020 |
Why?
|
| Antibodies | 1 | 2012 | 319 | 0.020 |
Why?
|
| Chimera | 1 | 2011 | 80 | 0.020 |
Why?
|
| Genome, Archaeal | 1 | 2010 | 6 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2011 | 69 | 0.020 |
Why?
|
| Checklist | 1 | 2011 | 98 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 1207 | 0.020 |
Why?
|
| Urogenital System | 1 | 2010 | 33 | 0.020 |
Why?
|
| Allergens | 1 | 2012 | 344 | 0.020 |
Why?
|
| Respiratory System | 1 | 2010 | 96 | 0.020 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2014 | 502 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1599 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1332 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2008 | 220 | 0.020 |
Why?
|
| Spores, Bacterial | 1 | 2007 | 23 | 0.020 |
Why?
|
| Gamma Rays | 1 | 2007 | 38 | 0.020 |
Why?
|
| Hydrolases | 1 | 2007 | 61 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3752 | 0.020 |
Why?
|
| Syphilis | 1 | 2008 | 95 | 0.020 |
Why?
|
| Methicillin Resistance | 1 | 2007 | 116 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2007 | 140 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 1665 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2007 | 330 | 0.020 |
Why?
|
| Introns | 1 | 2007 | 279 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2007 | 344 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 1046 | 0.010 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2012 | 951 | 0.010 |
Why?
|
| DNA Polymerase I | 1 | 2004 | 12 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2004 | 140 | 0.010 |
Why?
|
| Amino Acids | 1 | 2007 | 561 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 2004 | 151 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 190 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 365 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 308 | 0.010 |
Why?
|
| DNA Helicases | 1 | 2004 | 236 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2007 | 795 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 692 | 0.010 |
Why?
|
| DNA Damage | 1 | 2004 | 510 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 1211 | 0.010 |
Why?
|
| Alleles | 1 | 2004 | 1675 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1998 | 785 | 0.010 |
Why?
|
| Surface Properties | 1 | 1996 | 80 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1996 | 277 | 0.010 |
Why?
|
| Gene Library | 1 | 1996 | 212 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1996 | 732 | 0.010 |
Why?
|